Streetbeat News

Analyst Ratings

S

Morgan Stanley analyst Hamza Fodderwala maintains an Equal-Weight rating on SentinelOne (NYSE:S) and lowers the price target from $22 to $15.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2023 | 12:26 pm

HOOK

Morgan Stanley analyst Vikram Purohit maintains an Equal-Weight rating on HOOKIPA Pharma (NASDAQ:HOOK) and raises the price target from $2 to $2.25.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2023 | 12:26 pm

DG

Argus Research analyst Chris Graja maintains a Buy rating on Dollar General (NYSE:DG) but lowers the price target from $250 to $235.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2023 | 12:22 pm

PACB

Canaccord Genuity analyst Kyle Mikson maintains a Buy rating on Pacific Biosciences (NASDAQ:PACB) and raises the price target from $14 to $17.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2023 | 12:22 pm

IMGN

Canaccord Genuity analyst John Newman maintains a Buy rating on Immunogen (NASDAQ: IMGN) and raises the price target from $15 to $19.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2023 | 12:21 pm

CSSE

B. Riley Securities analyst Eric Wold maintains a Buy rating on Chicken Soup for the Soul (NASDAQ:CSSE) but lowers the price target from $7 to $5.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2023 | 12:19 pm

ONTO

Jefferies analyst Vedvati Shrotre maintains a Buy rating on Onto Innovation (NYSE:ONTO) and raises the price target from $100 to $123.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2023 | 12:17 pm

ELEV

Wedbush analyst Robert Driscoll maintains an Outperform rating on Elevation Oncology (NASDAQ:ELEV) and raises the price target from $4 to $6.

Portfolio Pulse from richadhand@benzinga.com

June 05, 2023 | 12:17 pm

RJF

Jefferies analyst Gerald O'Hara maintains a Buy rating on Raymond James Financial (NYSE:RJF) but lowers the price target from $136 to $112.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2023 | 12:17 pm

DAWN

Wedbush analyst Robert Driscoll reiterated an Outperform rating on Day One Biopharmaceutical (NASDAQ:DAWN) and maintained a $38 price target.

Portfolio Pulse from richadhand@benzinga.com

June 05, 2023 | 12:16 pm